ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mumps Vaccine Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-19C11605
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Mumps Vaccine Market Research Report 2022
BUY CHAPTERS

Global Mumps Vaccine Market Research Report 2024

Code: QYRE-Auto-19C11605
Report
June 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MedImmune
Johnson & Johnson
Merck& Co. Inc
Sanofi
Serum Institute of India
Bavarian Nordic
CSL Limited
Emergent Biosolutions
GlaxoSmithKline PLC
Panacea Biotec Ltd
Biological E Limited
Novavax Inc
Novartis
Sinovac Biotech Ltd.
Valneva SE
VBI Vaccines
PT Bio Farma
Astellas Pharma India
Bharat Biotech Ltd.
Incepta Vaccine Limited
Bionity
Sharp & Dohme Corp

Mumps Vaccine Market Size

The global Mumps Vaccine market was valued at US$ 369 million in 2023 and is anticipated to reach US$ 454.2 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

Mumps Vaccine Market

Mumps Vaccine Market

The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mumps Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mumps Vaccine.

Report Scope

The Mumps Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mumps Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mumps Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Mumps Vaccine Market Report

Report Metric Details
Report Name Mumps Vaccine Market
Accounted market size in 2023 US$ 369 million
Forecasted market size in 2030 US$ 454.2 million
CAGR 3.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Child
  • Adult
Segment by Application
  • Hospitals Pharmacies
  • Retail Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, GlaxoSmithKline, Panacea Biotec, Ltd., Biological E Limited, Bharat Biotech Ltd., Novavax, Inc., Novartis, Sinovac Biotech, Ltd., Incepta Vaccine Limited, Valneva SE, VBI Vaccines, PT Bio Farma, Sharp & Dohme Corp, Bionity
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mumps Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mumps Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Mumps Vaccine Market growing?

Ans: The Mumps Vaccine Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the Mumps Vaccine Market size in 2030?

Ans: The Mumps Vaccine Market size in 2030 will be US$ 454.2 million.

Who are the main players in the Mumps Vaccine Market report?

Ans: The main players in the Mumps Vaccine Market are MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, GlaxoSmithKline, Panacea Biotec, Ltd., Biological E Limited, Bharat Biotech Ltd., Novavax, Inc., Novartis, Sinovac Biotech, Ltd., Incepta Vaccine Limited, Valneva SE, VBI Vaccines, PT Bio Farma, Sharp & Dohme Corp, Bionity

What are the Application segmentation covered in the Mumps Vaccine Market report?

Ans: The Applications covered in the Mumps Vaccine Market report are Hospitals Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Mumps Vaccine Market report?

Ans: The Types covered in the Mumps Vaccine Market report are Child, Adult

1 Mumps Vaccine Market Overview
1.1 Product Overview and Scope of Mumps Vaccine
1.2 Mumps Vaccine Segment by Type
1.2.1 Global Mumps Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Child
1.2.3 Adult
1.3 Mumps Vaccine Segment by Application
1.3.1 Global Mumps Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Mumps Vaccine Market Size Estimates and Forecasts
1.4.1 Global Mumps Vaccine Revenue 2019-2030
1.4.2 Global Mumps Vaccine Sales 2019-2030
1.4.3 Global Mumps Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mumps Vaccine Market Competition by Manufacturers
2.1 Global Mumps Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mumps Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mumps Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Mumps Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mumps Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mumps Vaccine, Product Type & Application
2.7 Mumps Vaccine Market Competitive Situation and Trends
2.7.1 Mumps Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mumps Vaccine Players Market Share by Revenue
2.7.3 Global Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mumps Vaccine Retrospective Market Scenario by Region
3.1 Global Mumps Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mumps Vaccine Global Mumps Vaccine Sales by Region: 2019-2030
3.2.1 Global Mumps Vaccine Sales by Region: 2019-2024
3.2.2 Global Mumps Vaccine Sales by Region: 2025-2030
3.3 Global Mumps Vaccine Global Mumps Vaccine Revenue by Region: 2019-2030
3.3.1 Global Mumps Vaccine Revenue by Region: 2019-2024
3.3.2 Global Mumps Vaccine Revenue by Region: 2025-2030
3.4 North America Mumps Vaccine Market Facts & Figures by Country
3.4.1 North America Mumps Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mumps Vaccine Sales by Country (2019-2030)
3.4.3 North America Mumps Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mumps Vaccine Market Facts & Figures by Country
3.5.1 Europe Mumps Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mumps Vaccine Sales by Country (2019-2030)
3.5.3 Europe Mumps Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mumps Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Mumps Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mumps Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Mumps Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mumps Vaccine Market Facts & Figures by Country
3.7.1 Latin America Mumps Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mumps Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Mumps Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mumps Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mumps Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mumps Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mumps Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mumps Vaccine Sales by Type (2019-2030)
4.1.1 Global Mumps Vaccine Sales by Type (2019-2024)
4.1.2 Global Mumps Vaccine Sales by Type (2025-2030)
4.1.3 Global Mumps Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Mumps Vaccine Revenue by Type (2019-2030)
4.2.1 Global Mumps Vaccine Revenue by Type (2019-2024)
4.2.2 Global Mumps Vaccine Revenue by Type (2025-2030)
4.2.3 Global Mumps Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Mumps Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mumps Vaccine Sales by Application (2019-2030)
5.1.1 Global Mumps Vaccine Sales by Application (2019-2024)
5.1.2 Global Mumps Vaccine Sales by Application (2025-2030)
5.1.3 Global Mumps Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Mumps Vaccine Revenue by Application (2019-2030)
5.2.1 Global Mumps Vaccine Revenue by Application (2019-2024)
5.2.2 Global Mumps Vaccine Revenue by Application (2025-2030)
5.2.3 Global Mumps Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Mumps Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MedImmune
6.1.1 MedImmune Corporation Information
6.1.2 MedImmune Description and Business Overview
6.1.3 MedImmune Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MedImmune Mumps Vaccine Product Portfolio
6.1.5 MedImmune Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Mumps Vaccine Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co., Inc. Mumps Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Mumps Vaccine Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India Mumps Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Corporation Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bavarian Nordic Mumps Vaccine Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Astellas Pharma India
6.6.1 Astellas Pharma India Corporation Information
6.6.2 Astellas Pharma India Description and Business Overview
6.6.3 Astellas Pharma India Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astellas Pharma India Mumps Vaccine Product Portfolio
6.7.5 Astellas Pharma India Recent Developments/Updates
6.8 CSL Limited
6.8.1 CSL Limited Corporation Information
6.8.2 CSL Limited Description and Business Overview
6.8.3 CSL Limited Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSL Limited Mumps Vaccine Product Portfolio
6.8.5 CSL Limited Recent Developments/Updates
6.9 Emergent BioSolutions
6.9.1 Emergent BioSolutions Corporation Information
6.9.2 Emergent BioSolutions Description and Business Overview
6.9.3 Emergent BioSolutions Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Emergent BioSolutions Mumps Vaccine Product Portfolio
6.9.5 Emergent BioSolutions Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GlaxoSmithKline Mumps Vaccine Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Panacea Biotec, Ltd.
6.11.1 Panacea Biotec, Ltd. Corporation Information
6.11.2 Panacea Biotec, Ltd. Mumps Vaccine Description and Business Overview
6.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Panacea Biotec, Ltd. Mumps Vaccine Product Portfolio
6.11.5 Panacea Biotec, Ltd. Recent Developments/Updates
6.12 Biological E Limited
6.12.1 Biological E Limited Corporation Information
6.12.2 Biological E Limited Mumps Vaccine Description and Business Overview
6.12.3 Biological E Limited Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biological E Limited Mumps Vaccine Product Portfolio
6.12.5 Biological E Limited Recent Developments/Updates
6.13 Bharat Biotech Ltd.
6.13.1 Bharat Biotech Ltd. Corporation Information
6.13.2 Bharat Biotech Ltd. Mumps Vaccine Description and Business Overview
6.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Bharat Biotech Ltd. Mumps Vaccine Product Portfolio
6.13.5 Bharat Biotech Ltd. Recent Developments/Updates
6.14 Novavax, Inc.
6.14.1 Novavax, Inc. Corporation Information
6.14.2 Novavax, Inc. Mumps Vaccine Description and Business Overview
6.14.3 Novavax, Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Novavax, Inc. Mumps Vaccine Product Portfolio
6.14.5 Novavax, Inc. Recent Developments/Updates
6.15 Novartis
6.15.1 Novartis Corporation Information
6.15.2 Novartis Mumps Vaccine Description and Business Overview
6.15.3 Novartis Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Novartis Mumps Vaccine Product Portfolio
6.15.5 Novartis Recent Developments/Updates
6.16 Sinovac Biotech, Ltd.
6.16.1 Sinovac Biotech, Ltd. Corporation Information
6.16.2 Sinovac Biotech, Ltd. Mumps Vaccine Description and Business Overview
6.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Product Portfolio
6.16.5 Sinovac Biotech, Ltd. Recent Developments/Updates
6.17 Incepta Vaccine Limited
6.17.1 Incepta Vaccine Limited Corporation Information
6.17.2 Incepta Vaccine Limited Mumps Vaccine Description and Business Overview
6.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Incepta Vaccine Limited Mumps Vaccine Product Portfolio
6.17.5 Incepta Vaccine Limited Recent Developments/Updates
6.18 Valneva SE
6.18.1 Valneva SE Corporation Information
6.18.2 Valneva SE Mumps Vaccine Description and Business Overview
6.18.3 Valneva SE Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Valneva SE Mumps Vaccine Product Portfolio
6.18.5 Valneva SE Recent Developments/Updates
6.19 VBI Vaccines
6.19.1 VBI Vaccines Corporation Information
6.19.2 VBI Vaccines Mumps Vaccine Description and Business Overview
6.19.3 VBI Vaccines Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 VBI Vaccines Mumps Vaccine Product Portfolio
6.19.5 VBI Vaccines Recent Developments/Updates
6.20 PT Bio Farma
6.20.1 PT Bio Farma Corporation Information
6.20.2 PT Bio Farma Mumps Vaccine Description and Business Overview
6.20.3 PT Bio Farma Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 PT Bio Farma Mumps Vaccine Product Portfolio
6.20.5 PT Bio Farma Recent Developments/Updates
6.21 Sharp & Dohme Corp
6.21.1 Sharp & Dohme Corp Corporation Information
6.21.2 Sharp & Dohme Corp Mumps Vaccine Description and Business Overview
6.21.3 Sharp & Dohme Corp Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Sharp & Dohme Corp Mumps Vaccine Product Portfolio
6.21.5 Sharp & Dohme Corp Recent Developments/Updates
6.22 Bionity
6.22.1 Bionity Corporation Information
6.22.2 Bionity Mumps Vaccine Description and Business Overview
6.22.3 Bionity Mumps Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Bionity Mumps Vaccine Product Portfolio
6.22.5 Bionity Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mumps Vaccine Industry Chain Analysis
7.2 Mumps Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mumps Vaccine Production Mode & Process
7.4 Mumps Vaccine Sales and Marketing
7.4.1 Mumps Vaccine Sales Channels
7.4.2 Mumps Vaccine Distributors
7.5 Mumps Vaccine Customers
8 Mumps Vaccine Market Dynamics
8.1 Mumps Vaccine Industry Trends
8.2 Mumps Vaccine Market Drivers
8.3 Mumps Vaccine Market Challenges
8.4 Mumps Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
MedImmune
Johnson & Johnson
Merck& Co. Inc
Sanofi
Serum Institute of India
Bavarian Nordic
CSL Limited
Emergent Biosolutions
GlaxoSmithKline PLC
Panacea Biotec Ltd
Biological E Limited
Novavax Inc
Novartis
Sinovac Biotech Ltd.
Valneva SE
VBI Vaccines
PT Bio Farma
Astellas Pharma India
Bharat Biotech Ltd.
Incepta Vaccine Limited
Bionity
Sharp & Dohme Corp
List of Tables
    Table 1. Global Mumps Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Mumps Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Mumps Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Mumps Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Mumps Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Mumps Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Mumps Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Mumps Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Mumps Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Mumps Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Mumps Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Mumps Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Mumps Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mumps Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Mumps Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Mumps Vaccine Sales by Region (2019-2024) & (K Units)
    Table 18. Global Mumps Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Mumps Vaccine Sales by Region (2025-2030) & (K Units)
    Table 20. Global Mumps Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Mumps Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Mumps Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Mumps Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Mumps Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Mumps Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Mumps Vaccine Sales by Country (2019-2024) & (K Units)
    Table 27. North America Mumps Vaccine Sales by Country (2025-2030) & (K Units)
    Table 28. North America Mumps Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Mumps Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Mumps Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Mumps Vaccine Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Mumps Vaccine Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Mumps Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Mumps Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Mumps Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Mumps Vaccine Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Mumps Vaccine Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Mumps Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Mumps Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Mumps Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Mumps Vaccine Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Mumps Vaccine Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Mumps Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Mumps Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Mumps Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Mumps Vaccine Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Mumps Vaccine Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Mumps Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Mumps Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Mumps Vaccine Sales (K Units) by Type (2019-2024)
    Table 51. Global Mumps Vaccine Sales (K Units) by Type (2025-2030)
    Table 52. Global Mumps Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Mumps Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Mumps Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Mumps Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Mumps Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Mumps Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Mumps Vaccine Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Mumps Vaccine Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Mumps Vaccine Sales (K Units) by Application (2019-2024)
    Table 61. Global Mumps Vaccine Sales (K Units) by Application (2025-2030)
    Table 62. Global Mumps Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Mumps Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Mumps Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Mumps Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Mumps Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Mumps Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Mumps Vaccine Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Mumps Vaccine Price (US$/Unit) by Application (2025-2030)
    Table 70. MedImmune Corporation Information
    Table 71. MedImmune Description and Business Overview
    Table 72. MedImmune Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. MedImmune Mumps Vaccine Product
    Table 74. MedImmune Recent Developments/Updates
    Table 75. Johnson & Johnson Corporation Information
    Table 76. Johnson & Johnson Description and Business Overview
    Table 77. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Johnson & Johnson Mumps Vaccine Product
    Table 79. Johnson & Johnson Recent Developments/Updates
    Table 80. Merck & Co., Inc. Corporation Information
    Table 81. Merck & Co., Inc. Description and Business Overview
    Table 82. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Merck & Co., Inc. Mumps Vaccine Product
    Table 84. Merck & Co., Inc. Recent Developments/Updates
    Table 85. Sanofi Corporation Information
    Table 86. Sanofi Description and Business Overview
    Table 87. Sanofi Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Sanofi Mumps Vaccine Product
    Table 89. Sanofi Recent Developments/Updates
    Table 90. Serum Institute of India Corporation Information
    Table 91. Serum Institute of India Description and Business Overview
    Table 92. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Serum Institute of India Mumps Vaccine Product
    Table 94. Serum Institute of India Recent Developments/Updates
    Table 95. Bavarian Nordic Corporation Information
    Table 96. Bavarian Nordic Description and Business Overview
    Table 97. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Bavarian Nordic Mumps Vaccine Product
    Table 99. Bavarian Nordic Recent Developments/Updates
    Table 100. Astellas Pharma India Corporation Information
    Table 101. Astellas Pharma India Description and Business Overview
    Table 102. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Astellas Pharma India Mumps Vaccine Product
    Table 104. Astellas Pharma India Recent Developments/Updates
    Table 105. CSL Limited Corporation Information
    Table 106. CSL Limited Description and Business Overview
    Table 107. CSL Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. CSL Limited Mumps Vaccine Product
    Table 109. CSL Limited Recent Developments/Updates
    Table 110. Emergent BioSolutions Corporation Information
    Table 111. Emergent BioSolutions Description and Business Overview
    Table 112. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Emergent BioSolutions Mumps Vaccine Product
    Table 114. Emergent BioSolutions Recent Developments/Updates
    Table 115. GlaxoSmithKline Corporation Information
    Table 116. GlaxoSmithKline Description and Business Overview
    Table 117. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. GlaxoSmithKline Mumps Vaccine Product
    Table 119. GlaxoSmithKline Recent Developments/Updates
    Table 120. Panacea Biotec, Ltd. Corporation Information
    Table 121. Panacea Biotec, Ltd. Description and Business Overview
    Table 122. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Panacea Biotec, Ltd. Mumps Vaccine Product
    Table 124. Panacea Biotec, Ltd. Recent Developments/Updates
    Table 125. Biological E Limited Corporation Information
    Table 126. Biological E Limited Description and Business Overview
    Table 127. Biological E Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Biological E Limited Mumps Vaccine Product
    Table 129. Biological E Limited Recent Developments/Updates
    Table 130. Bharat Biotech Ltd. Corporation Information
    Table 131. Bharat Biotech Ltd. Description and Business Overview
    Table 132. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Bharat Biotech Ltd. Mumps Vaccine Product
    Table 134. Bharat Biotech Ltd. Recent Developments/Updates
    Table 135. Novavax, Inc. Corporation Information
    Table 136. Novavax, Inc. Description and Business Overview
    Table 137. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Novavax, Inc. Mumps Vaccine Product
    Table 139. Novavax, Inc. Recent Developments/Updates
    Table 140. Novartis Corporation Information
    Table 141. Novartis Description and Business Overview
    Table 142. Novartis Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Novartis Mumps Vaccine Product
    Table 144. Novartis Recent Developments/Updates
    Table 145. Sinovac Biotech, Ltd. Corporation Information
    Table 146. Sinovac Biotech, Ltd. Description and Business Overview
    Table 147. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Sinovac Biotech, Ltd. Mumps Vaccine Product
    Table 149. Sinovac Biotech, Ltd. Recent Developments/Updates
    Table 150. Incepta Vaccine Limited Corporation Information
    Table 151. Incepta Vaccine Limited Description and Business Overview
    Table 152. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Incepta Vaccine Limited Mumps Vaccine Product
    Table 154. Incepta Vaccine Limited Recent Developments/Updates
    Table 155. Valneva SE Corporation Information
    Table 156. Valneva SE Description and Business Overview
    Table 157. Valneva SE Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 158. Valneva SE Mumps Vaccine Product
    Table 159. Valneva SE Recent Developments/Updates
    Table 160. VBI Vaccines Corporation Information
    Table 161. VBI Vaccines Description and Business Overview
    Table 162. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 163. VBI Vaccines Mumps Vaccine Product
    Table 164. VBI Vaccines Recent Developments/Updates
    Table 165. PT Bio Farma Corporation Information
    Table 166. PT Bio Farma Description and Business Overview
    Table 167. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 168. PT Bio Farma Mumps Vaccine Product
    Table 169. PT Bio Farma Recent Developments/Updates
    Table 170. Sharp & Dohme Corp Corporation Information
    Table 171. Sharp & Dohme Corp Description and Business Overview
    Table 172. Sharp & Dohme Corp Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 173. Sharp & Dohme Corp Mumps Vaccine Product
    Table 174. Sharp & Dohme Corp Recent Developments/Updates
    Table 175. Bionity Corporation Information
    Table 176. Bionity Description and Business Overview
    Table 177. Bionity Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 178. Bionity Mumps Vaccine Product
    Table 179. Bionity Recent Developments/Updates
    Table 180. Key Raw Materials Lists
    Table 181. Raw Materials Key Suppliers Lists
    Table 182. Mumps Vaccine Distributors List
    Table 183. Mumps Vaccine Customers List
    Table 184. Mumps Vaccine Market Trends
    Table 185. Mumps Vaccine Market Drivers
    Table 186. Mumps Vaccine Market Challenges
    Table 187. Mumps Vaccine Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Mumps Vaccine
    Figure 2. Global Mumps Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Mumps Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Child Product Picture
    Figure 5. Adult Product Picture
    Figure 6. Global Mumps Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Mumps Vaccine Market Share by Application in 2023 & 2030
    Figure 8. Hospitals Pharmacies
    Figure 9. Retail Pharmacies
    Figure 10. Global Mumps Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Mumps Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Mumps Vaccine Sales (2019-2030) & (K Units)
    Figure 13. Global Mumps Vaccine Average Price (US$/Unit) & (2019-2030)
    Figure 14. Mumps Vaccine Report Years Considered
    Figure 15. Mumps Vaccine Sales Share by Manufacturers in 2023
    Figure 16. Global Mumps Vaccine Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Mumps Vaccine Players: Market Share by Revenue in 2023
    Figure 18. Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Mumps Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Mumps Vaccine Sales Market Share by Country (2019-2030)
    Figure 21. North America Mumps Vaccine Revenue Market Share by Country (2019-2030)
    Figure 22. United States Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Mumps Vaccine Sales Market Share by Country (2019-2030)
    Figure 25. Europe Mumps Vaccine Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Mumps Vaccine Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Mumps Vaccine Revenue Market Share by Region (2019-2030)
    Figure 33. China Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Mumps Vaccine Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Mumps Vaccine Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Mumps Vaccine Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Mumps Vaccine Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Mumps Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Mumps Vaccine by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Mumps Vaccine by Type (2019-2030)
    Figure 54. Global Mumps Vaccine Price (US$/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Mumps Vaccine by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Mumps Vaccine by Application (2019-2030)
    Figure 57. Global Mumps Vaccine Price (US$/Unit) by Application (2019-2030)
    Figure 58. Mumps Vaccine Value Chain
    Figure 59. Mumps Vaccine Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions